RESEARCH-USE BIOSIMILAR ANTIBODY
Torudokimab
Monoclonal antibody · IgG4
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
TARGETIL33
YMonoclonal antibody
CATALOGSC-BS-096
CATALOG NUMBERSC-BS-096
MOLECULAR WEIGHTApprox. 145.22 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
Torudokimab is a recombinant research-use antibody directed against IL33.